1. Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R
   Anna Niescioruk et al, 2017, J Nanopart Res CrossRef
2. Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation
   F Shi et al, 2017, Oncogene CrossRef
3. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1
   Karolina Grabowska et al, 2017, Bioorganic & Medicinal Chemistry CrossRef
4. Regulatory T cells in the treatment of disease
   Amir Sharabi et al, 2018, Nat Rev Drug Discov CrossRef
5. An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
   Valentina Perotti et al, 2019, Oncogene CrossRef
6. Rational, computer-enabled peptide drug design: principles, methods, applications and future directions
   David J Diller et al, 2015, Future Medicinal Chemistry CrossRef
7. Neuropilins as Signaling Hubs, Controlling Tyrosine Kinases and Other Cell Surface Receptors
   Sabrina Rizzolio et al, 2017 CrossRef
8. Increased expression of TLR7 and TLR9 in alopecia areata
   Hoon Kang et al, 2019, Exp Dermatol CrossRef
9. Eyes absent gene (EYA1) is a pathogenic driver and a therapeutic target for melanoma
   Joshua Jiawei Zhou et al, 2017, Oncotarget CrossRef
10. Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
    Federica Ruffini et al, 2017, Oncotarget CrossRef
11. Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages
    Ji Young Kang et al, 2020, JCM CrossRef
12. Vascular NRP2 triggers PNET angiogenesis by activating the SSH1-cofilin axis
    Xi Luo et al, 2020, Cell Biosci CrossRef
13. SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
    Elisabetta Valentini et al, 2021, J Exp Clin Cancer Res CrossRef
14. Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
    Zena Wehbe et al, 2021, Front. Immunol. CrossRef
15. Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress
    Virginia Napolitano et al, 2021, Cancers CrossRef
16. Neuropilins as Cancer Biomarkers: A Focus on Neuronal Origin and Specific Cell Functions
    Dakshnapriya Balasubbramanian et al, 2022 CrossRef
17. Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis
    Eloisa Romano et al, 2022, Life CrossRef
18. Modification of α‐Tocopherol Succinate with a Tumor‐targeting Peptide Conjugate Enhances the Antitumor Efficacy of a Paclitaxel‐loaded Lipid Aggregate
    Sujan Kumar Mondal et al, 2022, Chemistry — An Asian Journal CrossRef
19. Next-generation immunotherapy: regulatory T-cells
    A. V Churov et al, 2021, Genes & Cells CrossRef
20. TARGETING OF PDGF-C/NRP-1 AUTOCRINE LOOP AS A NEW STRATEGY FOR COUNTERACTING THE INVASIVENESS OF MELANOMA RESISTANT TO BRAF INHIBITORS
    Federica Ruffini et al, 2023, Pharmacological Research CrossRef
21. Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19?
    Kiarash Saleki et al, 2023, Biomedicine & Pharmacotherapy CrossRef
22. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives
    Mohammad Malekan et al, 2024, Life Sciences CrossRef
23. A Spatial Transcriptomics Browser for Discovering Gene Expression Landscapes across Microscopic Tissue Sections
    Maria Schmidt et al, 2024, CIMB CrossRef
24. Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential
    Claudia Ceci et al, 2024, Biomedicine & Pharmacotherapy CrossRef